Agendia B.V. (Amsterdam, The Netherlands) and Medvet Science (Adelaide, Australia), the wholly owned subsidiary of the Institute of Medical and Veterinary Science, one of Australia's leading medical research organisations and a major provider of medical testing services to hospitals and the community in Australia, have entered into an exclusive distribution agreement for distribution of the MammaPrint breast cancer gene prognosis test in Australia.
